American Century Companies’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.3M | Buy |
834,781
+11,165
| +1% | +$151K | 0.01% | 1323 |
|
|
2025
Q1 | $13.1M | Sell |
823,616
-25,014
| -3% | -$397K | 0.01% | 1222 |
|
|
2024
Q4 | $10.4M | Sell |
848,630
-83,020
| -9% | -$1.02M | 0.01% | 1322 |
|
|
2024
Q3 | $11.3M | Buy |
931,650
+188,510
| +25% | +$2.28M | 0.01% | 1261 |
|
|
2024
Q2 | $8.69M | Buy |
743,140
+23,170
| +3% | +$271K | 0.01% | 1295 |
|
|
2024
Q1 | $9.29M | Buy |
719,970
+40,709
| +6% | +$526K | 0.01% | 1236 |
|
|
2023
Q4 | $5.84M | Buy |
679,261
+259,585
| +62% | +$2.23M | ﹤0.01% | 1347 |
|
|
2023
Q3 | $3.99M | Buy |
419,676
+167
| +0% | +$1.59K | ﹤0.01% | 1410 |
|
|
2023
Q2 | $7.15M | Buy |
419,509
+1,606
| +0.4% | +$27.4K | 0.01% | 1180 |
|
|
2023
Q1 | $6.53M | Buy |
+417,903
| New | +$6.53M | 0.01% | 1165 |
|